Monday, 6 April 2020

Ligation Devices Market Trends- Industry Demand and Forecast to 2024


Global Ligation Devices Market Report: By Product (Handheld Instruments, Accessories), Procedure (Minimally Invasive Surgery, Open Surgery), and Application (Gastrointestinal and Abdominal, Gynecological, Urological Applications)—Global Forecast till 2024

The global ligation devices market trends is expected to register a CAGR of 6.7% during the forecast period of 2019 to 2024.
Market Research Future (MRFR) recognizes the following companies as the key players in the global Ligation Devices Market that includes Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc.
Market Highlights
Ligation devices are used during surgeries for closing incisions or to join separated organs/tissue parts. Favorable reimbursement policies, rising healthcare expenditure, an increasing number of surgeries, and growing research and development expenditures are the factors driving the market growth. According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,000 per year. However, the high cost of surgery and related side effects are estimated to restraint the market growth.
Segmentation
The global ligation devices market is segmented based on product, procedure, application, end user, and region.

On the basis of product, the market is segmented into handheld instruments and accessories. Based on procedure, the market is segmented into minimally invasive surgery and open surgery. The application segment is segmented into gastrointestinal and abdominal applications, cardiovascular applications, gynecological applications, urological applications, and others. Based on the end user, the market is segmented into hospitals & clinics, ambulatory surgical center, and others.
Regional Analysis
The Americas dominated the global ligation devices market in 2018. Factors such as increasing healthcare expenditure and the rising incidence of chronic diseases are the major drivers within the region.
In 2018, it was estimated that Europe stood second in the global ligation devices market owing to increasing awareness, government support, development of technologically advanced medical products, and a growing number of surgeries. Moreover, the presence of developed economies (Germany, France, UK) boosts the market growth.

Asia-Pacific was the fastest growing region for the global ligation devices market in 2018. Factors such as increasing healthcare infrastructure, favorable government policies, an increasing number of surgeries and rising medical tourism drive the market growth within the region. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to be one of the fastest growing industries and is estimated to reach USD 280 billion by 2020 with a CAGR of 22.87% from 2015.
On the other hand, the Middle East and Africa held the least share in the global ligation devices market. Factors such as the presence of poor economies and low per capita income, especially within the African region make the market to lag within the region.

Key Players

Some of the key players in the global ligation devices market are Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc., and others.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
…..
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Posted by at No comments:
Labels: , ,

Global Analysis On Diabetes Monitors Market 2020

Diabetes monitors market Insights 
Rapid urbanization, a growing geriatric population, changing lifestyles and a prevalence of unbalanced diets have contributed to the increasing occurrence of type 2 diabetes in the global population. This has inevitably created a more widespread demand for diabetes monitors. Both type 1 and 2 diabetes are widespread across the globe, with type 2 being the more commonly occurring form of diabetes of the two. According to the International Diabetes Federation 1 in 11 adults (425 millions) has diabetes and over two-thirds of these cases are recorded in urban areas. While, there is no cure for the disease, it can be managed through ongoing monitoring, the demand for appropriate diabetic monitoring technologies has incited considerable growth and will continue to do so as the market develops during the forecast period.
Market Research Future (MRFR) has published a comprehensive market report that identifies trends and restraints that affect growth. The report also identifies market opportunities based on extensive analysis of the diabetes monitors market. MRFR has revealed that the global market is estimated to reach a value of USD $17.4 billion by 2023 and experience a CAGR of 8.3% during the forecast period (2017 - 2023). 
The global diabetes monitors market is projected to witness considerable growth during the forecast period, this is due to the huge research and development investment in advancing treatment options and providing monitoring solutions that are semi to non-invasive. Governments and other regulatory bodies worldwide, are encouraging innovative relevant technologies for diabetes monitoring. Although high costs associated with diagnosis & treatment and the inconvenience associated with common monitoring devices (finger pricking) are expected to hamper market growth, the demand for efficient and affordable monitoring methods is likely to propel growth as innovation progresses.
Market Segmentation
Segmental analysis of the global diabetes monitors market has been based on sample, type, component and end-users.
Based on sample, the market has been segmented into blood samples, urine samples, sweat samples and others. Blood samples are the largest market segment and is expected to possess a 75.70% share and witness a CAGR of 8.6% during the forecast period of 2017 to 2023. 
Based on type, the market has been segmented into point sample test based glucose monitors, continuous glucose monitors and enzyme free sensor based glucose monitors. Continuous glucose monitors (CGM) have been further sub-segmented to include, disposable sensor based CGM and re-usable sensor based CGM
Based on components, the market has been classified into lancet, glucose test strips and sensors. Sensors have been sub-segmented into enzyme based sensors and enzyme free sensors.
Based on end users, the market has been segmented into diagnostic clinics, hospitals and home.

Regional Analysis
The Americas possess the largest global market share owing to the strong presence of leading market players, large investments in research & development, a well-developed health sector and a large patient population in the region. The high prevalence of diabetes in this area has prompted government and private organizations to actively encourage improvement of treatment options available. 
Europe holds the second largest global market share and like the Americas, this region has supportive government associations that drive research and development to improve existing monitoring technologies. The strong potential for viable treatment and monitoring innovations from this region are fueling market growth. 
Asia Pacific is predicted to be the fastest growing global market segment. Countries such as India and China count amongst countries with the highest occurrence of diabetes, the presence of a colossal patient population in the region is driving substantial growth for the region. There is a strong requirement for affordable monitoring devices and other relevant diabetes care which is attracting major players to cater to this region.
The Middle East and Africa includes countries such as the U.A.E., Qatar and Kuwait where an immensely rapid urbanization has led to a high number of diabetes diagnoses, thus driving growth for this market. However, due to the presence of impoverished and under developed economies of many African countries in this region is expected to limit growth during the forecast period.
Key Players
MRFR’s report analyzes the strategies of major players that participate in the competitive landscape of this market so as to provide relevant insights. Key players included in the report are LifeScan Inc., Panasonic, Dexcom Inc., Abbot Laboratories, F.Hoffmann La-Roche Ltd., Medtronic and Sanofi.  
Latest Industry News
Dexcom has announced Food and Drug Administration (FDA) approval of the Dexcom G6 CGM System. The device is developed to be used as a standalone CGM and for integration into automated insulin dosing (AID) devices. Perhaps the most impressive feature about this system is that it eliminated the need for finger sticks and is non-invasive. The sensor is also developed for longer use and will last 43% longer than previous version of the device.
Researchers at the UC San Diego Jacobs School of Engineering led by UC San Diego Centre for Wearable Sensors director and co-director have developed a glucose monitoring patch that is non-invasive. The patch is applied onto the skin like a temporary children's tattoo and contains electrodes that apply a minuscule electric current which forces molecules of glucose to rise to the surface for measurement. This monitoring method has enrolled for clinical trials. The method is expected to potentially be a viable non-invasive, user friendly and affordable monitoring solution.
Read More @ https://www.marketresearchfuture.com/reports/diabetes-monitors-market-4781
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com


Posted by at No comments:
Labels: , ,

Biological Stains Market Trends 2020 is Expected to Surge with 7.1%CAGR by 2023, Covering Major Applications, Product types, Key players, Focused Regions, Forecasting

Global Biological Stains Market: Information by Type (Acid Fuchsin, Congo Red, Eosin, and Others), Application (Histology, Bacteriology, Protein Staining, Gram Staining, and Others), End-User (Diagnostic Laboratories and Others)–Global Forecast Till 2023
Biological Stains Market Highlights
Staining is a supplementary technique used to enhance the contrast in the microscopic image.  Biological stains are essential in the identification of physical, chemical and structural characteristics of biological content. The increasing use of stains in healthcare and life sciences research, the surge in the number of infectious diseases and increasing commercial use of stains are the factors responsible for the growth of the biological stains market. Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as new product launches, and merger and acquisition activities are contributing to the growth of the market. For instance, in January 2017, Bio-Rad Laboratories announced the acquisition of RainDance Technologies for approximately USD  87 million. RainDance Technologies offers products such as microdroplet solutions for the early detection of cancer and other diseases.
The high costs associated with biological stains, availability of substitutes and risk of contamination due to the use of biological stains are likely to hinder the market growth during the forecast period.
Global Biological Stains Market, by Region
Americas
  • North America
  • US
  • Canada
  • South America
Europe
  • Western Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Rest of Western Europe
  • Eastern Europe
Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
Middle East & Africa
  • Middle East
  • Africa
Segmentation
The global biological stains market trends has been segmented on the basis of type, application, and end-user.
On the basis of type, the market has been classified as acid fuchsin, Congo red, crystal violet, eosin, methylene blue, iodine, safranin, and others. The eosin segment has been further divided into eosin Y, alcoholic eosin Y, eosin B, eosin- phloxine, and picro-eosin. The application segment has been further divided into histology, bacteriology, protein staining, gram staining, protein staining, DNA staining, and fluorescence microscopy.
The market, by end-user, has been segmented into diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies, and others.
Key Players
Some of the key players in the global biological stains market are Thermo Fisher Scientific Inc., Avantor, Becton, Dickinson and Company, Beckman Coulter, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc, Water Corporation, and bioMérieux SA.
 About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , ,

Bioanalytical Testing Services Market Company-Size, Trends and Forecast to 2023

The Global Bioanalytical Testing Services Market is expected to exhibit a CAGR of 12.95% over the forecast period from 2018 to 2023, according to a new research report from Market Research Future (MRFR). The report presents readers with a clear picture of the global bioanalytical testing services market’s growth potential over the forecast period based on a detailed study of the market’s major historical growth drivers and restraints. The leading players operating in the global bioanalytical testing services market and their successful strategies are also assessed in detail in the report to provide readers with a clear picture of the competitive landscape of the market.
Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6573
Bioanalytical testing services are used to detect and measure the presence of drugs and related metabolites in the human body. The bioanalytical testing services market comprises a major part of the biomedical research sector, as it plays a crucial role in determining whether a drug can deliver its expected efficacy and whether it is safe for human consumption. Thus, bioanalytical testing services play a vital part in expediting the drug delivery process and make it more convenient and easier for manufacturers to gather relevant results in the shortest time. The increasing demand for advanced bioanalytical testing services from the medical research sector is likely to be the major driver for the market over the forecast period.
The growing global medical research sector is likely to drive the global bioanalytical testing services market over the forecast period. Due to the growing prevalence of communicable as well as noncommunicable diseases, the global medical research sector has been driven at a strong pace. This growth is likely to result in steady growth of the global bioanalytical testing services market over the forecast period, as bioanalytical testing services play a vital role in medical research. The growing prevalence of cancer has become a major concern for the healthcare sector and significant research efforts have been dedicated towards the eradication of cancer in the last few years. The increasing prevalence of communicable diseases is also likely to be a major driver for the bioanalytical testing services market over the forecast period.
Competitive Analysis:
Leading players in the global bioanalytical testing services market include Laboratory Corporation of America Holdings, Covance Inc., Toxikon, inVentiv Health, Pace Analytical Services LLC, Intertek Group plc, ICON Plc, SGS SA, Charles River Laboratories Inc., Pharmaceutical Product Development, and WuXi AppTec.
Industry Updates:
In January 2019, SGS expanded its Glasgow facility by adding more testing capacity.
Segmentation:
The global bioanalytical testing services market is segmented on the basis of test type, molecule type, and region.
By test type, the global bioanalytical testing services market Company is segmented into pharmacokinetics (PK), pharmacodynamics (PD), bioavailability, bioequivalence, and others.
By molecule type, the bioanalytical testing services market is divided into small and large molecules. The small molecules segment is sub-segmented into proprietary and generics, while the large molecules segment is divided into biomarkers, biosimilars, vaccines, and others.
Regional Analysis:
The global bioanalytical testing services market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa on the basis of region. The Americas is likely to be the major regional segment of the global bioanalytical testing services market over the forecast period due to the strong presence of medical research facilities in developed North American countries such as the U.S. and Canada. The strong presence of government support to medical research in these countries has also helped advance the cause of medical research and is likely to remain a major driver for the bioanalytical testing services market in the region over the forecast
period. The growing prevalence of cancer and other noncommunicable chronic diseases in North America is also a major driver for the bioanalytical testing services market in the region. The U.S. is a global hotspot for medical research, with several leading medicine and drug manufacturers having a strong presence in the country and the government providing a solid research infrastructure with solid scope for further development in the coming years.
Browse Complete 100 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/bioanalytical-testing-services-market-6573 
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: ,

Sunday, 5 April 2020

New Opportunities In Global Retinal Implants Market Trends With Economic Growth And Five Forces Analysis By 2023


Retinal implants have proven its mettle as a breakthrough therapy in the treatment of visual impairment. The global retinal implants market is perceived to be growing at a recurring rate and is expected to reach high revenue figures in the coming years, as per the analysis of Market Research Future (MRFR).  The global retinal implant market has been flourishing on account of the widespread prevalence of eye disorders across the globe. Growing cases of retinal disorders have induced high demand for retinal implants since they aid in the restoration of vision. Retinal implants have demonstrated significance for application in eye disorders which were once far-off impossible to achieve. The fact that these devices can be implanted with minimally invasive procedures has added to its popularity and driven the market. The rise in geriatric population is a crucial factor driving the growth of the retinal implant market. Owing to various health insufficiencies, the aging population is more susceptible to acquiring visual impairment and require Retinal implant Market Trends.
Retinal implants have proven its mettle as a breakthrough therapy in the treatment of visual impairment. The global retinal implants market is perceived to be growing at a recurring rate and is expected to reach high revenue figures in the coming years, as per the analysis of Market Research Future (MRFR).  The global retinal implant market has been flourishing on account of the widespread prevalence of eye disorders across the globe. Growing cases of retinal disorders have induced high demand for retinal implants since they aid in the restoration of vision. Retinal implants have demonstrated significance for application in eye disorders which were once far-off impossible to achieve. The fact that these devices can be implanted with minimally invasive procedures has added to its popularity and driven the market. The rise in geriatric population is a crucial factor driving the growth of the retinal implant market. Owing to various health insufficiencies, the aging population is more susceptible to acquiring visual impairment and require retinal implant.
Request Free Sample @https://www.marketresearchfuture.com/sample_request/6580
Substantial investment in R&D activities by various medical device manufacturers and governments have led to the development of advanced retinal implants which can be successfully implanted in patients. Extensive clinical trial activities have also contributed to the growth of the market. Few retinal implants have already cleared clinical trials, and many more are underway which is expected to spur the market in the future. In addition, the rise in a number of FDA approvals has been a plus for the growth of the global retinal implants market.
A large number of retinal implants are due for approval and patent from various regulatory authorities, the market stores opportunities for expansion. Also, expected expansion in reimbursement coverage for retinal implants is also expected to augment the market in the coming years. Other driving factors include the rise in the prevalence of degenerative diseases and raising awareness regarding the availability of the device which raises adoption. However, lack of skilled medical professionals with adequate knowledge of performing surgery and stringent and complex FDA approval process remains a significant hurdle for the growth of the global retinal implants market. High costs associated with retinal implants, the risk of biocompatibility and unknown long-term efficacy of the product are also expected to hinder adoption.
Segmentation
The global retinal implants market has been segmented into device type, disease indication, and end user. By device type, the market has been segmented into retina implant alpha AMS, Argus II, implantable miniature telescope, and others.  By disease indication, the market has been segmented into age-related macular degeneration (AMD) and retinitis pigmentosa. By end user, the market has been segmented into multi-specialty hospitals, ophthalmic clinics, and research institutes.
Access Report @ https://www.marketresearchfuture.com/reports/retinal-implants-market-6580
Regional Analysis
North America, Europe, Asia Pacific, and the Rest of the World are the key markets for retinal implants. North America accounts for a substantial share of the global market. Higher availability of the product, improving reimbursement scenario and higher affordability in the region supports the growth of the North America market for retinal implants. Presence of highly skilled surgeons to perform immensely complex surgical procedure also accelerates adoption in the region.
In Europe, the market is driven by an increase in R&D activities and the expansion of clinical trials.
Presence of developing countries such as India, China, and Japan, who outlay massive amounts on healthcare expenditure, coupled with growing disposable income and affordability supports the growth of the market in Asia Pacific.
Rest of the World market is expected to fare well in the coming years since various market players are foraying into the untapped regions to leverage the potential they offer for market expansion.
Competitive Landscape
Second Sight Medical Products, Inc.; Retina Implant AG,  VisionCare, Inc., Bionic Vision Australia (BVA), Bionic Eye Technologies, Inc., and Visus Technology, Inc. are the key players operating in the global retinal implants market.
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com



Posted by at No comments:
Labels: ,

Discover the Ligature Devices industry trends and analysis,2024


Market research future will be publishing a Half cooked research report on “Global  ligature Devices Market” that contains the information from 2019 to 2024. Ligation Devices Market is expected to grow at a CAGR 6.7% during the forecast period of 2019 to 2024.
Request Free Sample @ https://www.marketresearchfuture.com/sample_request/7794 
Market Research Future (MRFR) recognizes the following companies as the key players in the global Ligation Devices Market that includes Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc.
Market Highlights
Ligation devices are used during surgeries for closing incisions or to join separated organs/tissue parts. Favorable reimbursement policies, rising healthcare expenditure, an increasing number of surgeries, and growing research and development expenditures are the factors driving the market growth. According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,000 per year. However, the high cost of surgery and related side effects are estimated to restraint the market growth.
Regional Analysis
The Americas dominated the global ligation devices market in 2018. Factors such as increasing healthcare expenditure and the rising incidence of chronic diseases are the major drivers within the region.
In 2018, it was estimated that Europe stood second in the global ligation devices market owing to increasing awareness, government support, development of technologically advanced medical products, and a growing number of surgeries. Moreover, the presence of developed economies (Germany, France, UK) boosts the market growth.

Asia-Pacific was the fastest growing region for the global ligation devices market in 2018. Factors such as increasing healthcare infrastructure, favorable government policies, an increasing number of surgeries and rising medical tourism drive the market growth within the region. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to be one of the fastest growing industries and is estimated to reach USD 280 billion by 2020 with a CAGR of 22.87% from 2015.
On the other hand, the Middle East and Africa held the least share in the global ligation devices market. Factors such as the presence of poor economies and low per capita income, especially within the African region make the market to lag within the region.

Key Players

Some of the key players in the global ligation devices market are Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc., and others.
Segmentation
The global ligation devices market is segmented based on product, procedure, application, end user, and region.

On the basis of product, the market is segmented into handheld instruments and accessories. Based on procedure, the market is segmented into minimally invasive surgery and open surgery. The application segment is segmented into gastrointestinal and abdominal applications, cardiovascular applications, gynecological applications, urological applications, and others. Based on the end user, the market is segmented into hospitals & clinics, ambulatory surgical center, and others.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/ligation-devices-market-7794
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com



Posted by at No comments:
Labels: ,

Medication Management system Market Regional Trends, Size and Forecast to 2023


Market Insights

Market Research Future predicted that the global Medication Management system Market is set to reach the highest CAGR of 13.4% through the forecast period, 2018-2023.

Medication management focuses on improving medication use for the patient's condition. Interventions may include medication alignment, medication management, patient / family education about medications, and patient medication configuration simulations.
The growing geriatric population is one of the most important factors in the drug management market. Older people often have significant comorbidities that increase drug use and the risk of poor outcomes. According to a 2018 study published in Clinical Epidemiology, polypharmacy affects between 40% and 50% of older people in countries with high-income. Polypharmacy increases the risk of drug-related side effects in older people because more drugs are associated with a higher risk of harmful drug interactions. Several other factors, such as the emergence of funds in the healthcare sector and the need to reduce healthcare costs, are some of the drivers of the market.
However, the high costs of software implementation and service maintenance can hinder the market growth during the forecast period.
Market Segmentation
The global drug management market is segmented based on systems, services, delivery methods, and end-user.
The global system-based medication management market is divided into computerized physician order entry systems, clinical decision support systems, administration software, inventory management systems, automated dispensing systems, and assurance systems. Administration software segment is further classified as Bar Code Drug Delivery Software (BCMA) and Electronic Drug Management Software (eMAR). The automatic distributor's segment is further classified as centralized automated distribution systems and decentralized automated distribution systems (ADS). A centralized automated dosing system includes robots / dosing systems and automated carousels. The decentralized automated dispensing system (ADS) comprises automated decentralized unit dose metering systems, pharmacy-based decentralized automated dispensing systems, and service-based decentralized automated dispensing systems.
The services market segment is subdivided into point-of-care verification services and drug side effects monitoring.
The global market, on the basis of delivery mode, is divided into on-premise solutions, web-based solutions, and cloud-based solutions.
The market is segmented into pharmacies, hospitals, healthcare facilities, research institutes, and others, based on end-user.
Regional Outlook
The United States has dominated the global drug management market. This growth can be ascribed to the rise in the elderly population and the presence of the main market players in the region.
Europe ranked second in 2017 due to the presence of developed economies such as the United Kingdom, Germany, France, and other countries in the region, which is an engine for market growth.
The Asia Pacific region is likely to see the fastest growth in 2017. Factors such as health technology sector growth, increasing market penetration in the region, and growing government support for foreign investment provide regional markets in the region. Asia Pacific.
In addition, the Middle East and Africa had the lowest share of the global drug management market due to the existence of low per capita income and poor economies, especially in the African region. The Middle East region is considered an important market for the Middle East and Africa region.
Major Players
The leading players that are supporting the functioning of the global medication management market include General Electric Company, Siemens Ltd, Medical Information Technology, QuadraMed Affinity Corporation, Allscripts Healthcare Solutions, Cerner Corporation, Mckesson Corporation, Omnicell, Inc., Carefusion Corporation, Epic Systems Corporation, and Optum Inc.
Recent Updates
  • Omnicell, Inc., a leading  of medication management solutions for healthcare and pharmacy systems, has announced that Mercy, one of five US healthcare systems for Oklahoma, Arkansas, Missouri, and Kansas, will take over the management of medication in your service network through its Omnicell's automation and intelligence solutions. Omnicell works with major healthcare systems, such as Mercy, and the company launches its vision for independent pharmacies, a step-by-step plan for developing a fully automated zero-error drug management infrastructure. Based on automation, data intelligence, and specialized services, the autonomous pharmacy will allow pharmacists, nurses, physicians, and pharmacist staff to focus on patient and physician satisfaction.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:
Labels: ,
Subscribe to: Posts (Atom)